AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
- 1 October 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 22 (10), 1846-1855
- https://doi.org/10.1681/asn.2011010026
Abstract
The mechanisms underlying the association between obesity and progressive renal disease are not well understood. Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiology of kidney disease induced by a high-fat diet is unknown. In this study, we randomly assigned C57BL/6J mice to a standard or high-fat diet. After 1 week, mice fed a high-fat diet exhibited an increase in body weight, renal hypertrophy, an increase in urine H2O2 and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity. Urine ACR progressively increased after 4 weeks of a high-fat diet. After 12 weeks, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed. To determine whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 week. Although AMPK activation did not abrogate the weight gain, it reduced the renal hypertrophy, urine H2O2, and urine and renal MCP-1. In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells. In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.This publication has 37 references indexed in Scilit:
- TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1American Journal of Physiology-Renal Physiology, 2010
- AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In VivoCirculation Research, 2010
- Pirfenidone Is Renoprotective in Diabetic Kidney DiseaseJournal of the American Society of Nephrology, 2009
- The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeabilityAmerican Journal of Physiology-Renal Physiology, 2009
- Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cellsClinical and Experimental Immunology, 2009
- Adiponectin regulates albuminuria and podocyte function in miceJCI Insight, 2008
- AMP‐activated protein kinase – development of the energy sensor conceptThe Journal of Physiology, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- CCR2 modulates inflammatory and metabolic effects of high-fat feedingJCI Insight, 2006
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003